GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,011,000 | +110.4% | 88,277 | -1.3% | 0.00% | +100.0% |
Q2 2022 | $2,857,000 | -84.5% | 89,414 | -83.2% | 0.00% | -83.3% |
Q1 2022 | $18,384,000 | +49.7% | 530,693 | +26.5% | 0.01% | +50.0% |
Q4 2021 | $12,282,000 | +42.4% | 419,563 | +23.9% | 0.00% | +33.3% |
Q3 2021 | $8,626,000 | -38.5% | 338,507 | -15.5% | 0.00% | -25.0% |
Q2 2021 | $14,028,000 | -8.8% | 400,652 | +6.1% | 0.00% | -20.0% |
Q1 2021 | $15,383,000 | -13.4% | 377,506 | -8.0% | 0.01% | -16.7% |
Q4 2020 | $17,763,000 | -29.3% | 410,118 | -10.0% | 0.01% | -45.5% |
Q3 2020 | $25,110,000 | -14.5% | 455,437 | -2.0% | 0.01% | -15.4% |
Q2 2020 | $29,358,000 | +19.0% | 464,928 | -3.7% | 0.01% | 0.0% |
Q1 2020 | $24,670,000 | -36.7% | 482,863 | -1.6% | 0.01% | -7.1% |
Q4 2019 | $38,988,000 | +78.8% | 490,492 | +9.1% | 0.01% | +75.0% |
Q3 2019 | $21,807,000 | -6.0% | 449,416 | +1.9% | 0.01% | -11.1% |
Q2 2019 | $23,202,000 | -9.0% | 441,083 | -8.5% | 0.01% | -10.0% |
Q1 2019 | $25,505,000 | +26.2% | 481,869 | -2.1% | 0.01% | +11.1% |
Q4 2018 | $20,214,000 | +545.0% | 492,420 | +497.0% | 0.01% | +800.0% |
Q3 2018 | $3,134,000 | – | 82,486 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 177,414 | $14,103,000 | 11.50% |
Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |